Toronto, Ontario–(Newsfile Corp. – Le 21 mars/March 2025) – Nirvana Life Sciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares. As a result, the number of outstanding shares will be …
Read More »